Nigeria is confronting a dangerous convergence of public health threats as rising fatalities from Lassa fever coincide with a growing outbreak of cerebrospinal meningitis, prompting urgent warnings from the Nigeria Centre for Disease Control and Prevention (NCDC).
According to the agency’s Epidemiological Week 7 report released in early March 2026, the country has recorded a Lassa fever case fatality rate (CFR) of 23.0% a sharp increase from 19.7% reported during the same period in 2025. The escalation highlights a worsening outbreak driven largely by delayed diagnosis and treatment.
As of March 11, Nigeria has confirmed 326 Lassa fever cases and 75 deaths within the first seven weeks of the year. The outbreak spans 14 states and 58 Local Government Areas, with the highest burden concentrated in Bauchi State (33%), Ondo State (22%), Taraba State (19%), and Edo State (10%), collectively accounting for 84% of all confirmed infections.
Weekly data show a continued upward trend, with confirmed cases rising from 74 to 82 in Week 7 alone. Of particular concern is the infection of five healthcare workers within that same period, underscoring the heightened occupational risk faced by frontline medical personnel especially in facilities lacking specialized infectious disease protocols.
At the same time, the NCDC has issued a high-priority advisory on cerebrospinal meningitis (CSM), as dry season conditions across northern and central Nigeria intensify transmission risks. The disease, caused by the bacterium Neisseria meningitidis, thrives in environments marked by dust, heat, and low humidity conditions now prevalent across much of the country.
Speaking on the situation, Jide Idris, Director-General of the NCDC, warned that overcrowded living conditions in schools, residential areas, and internally displaced persons (IDP) camps are accelerating the spread of infection, describing the situation as a “perfect storm” for an outbreak.
Health experts say the rising Lassa fever fatality rate reflects deep structural weaknesses in Nigeria’s healthcare system. Chief among them is the issue of late clinical presentation. Many patients reportedly delay seeking medical attention, often resorting first to self-medication or traditional remedies, or misattributing early symptoms to malaria. By the time they reach appropriate health facilities, antiviral treatments such as Ribavirin are significantly less effective.
Economic barriers further complicate response efforts. High transportation costs, limited access to testing centers, and weak disease surveillance systems at the state level continue to hinder timely diagnosis and treatment. Data also indicate that individuals aged 21 to 30 years Nigeria’s most economically productive demographic are among the most affected.
The infection of 28 healthcare workers so far in 2026 points to persistent gaps in Infection Prevention and Control (IPC) measures, particularly in general outpatient settings where early warning signs are often missed.
Public health analysts warn that without stronger coordination at the state level, the situation may worsen. They stress the need for governments to subsidize specimen transportation, strengthen surveillance systems, and enforce mandatory IPC protocols across all healthcare facilities.
For the meningitis outbreak, experts are calling for immediate mass vaccination campaigns and widespread public awareness efforts, particularly around reducing overcrowding and improving ventilation during the peak dry season.
As Nigeria battles these parallel health emergencies, the coming weeks are expected to test both the resilience of its healthcare system and the effectiveness of its emergency response strategies.
and then